3,000 Shares in DaVita Inc. $DVA Acquired by Performance Wealth Partners LLC

Performance Wealth Partners LLC acquired a new position in shares of DaVita Inc. (NYSE:DVA) in the 2nd quarter, HoldingsChannel.com reports. The fund acquired 3,000 shares of the company’s stock, valued at approximately $667,000.

Several other large investors also recently bought and sold shares of the company. Value Investment Professionals LLC boosted its position in shares of DaVita by 2.0% in the 2nd quarter. Value Investment Professionals LLC now owns 2,501 shares of the company’s stock worth $556,000 after buying an additional 50 shares in the last quarter. Kesler Norman & Wride LLC increased its holdings in DaVita by 0.8% during the 1st quarter. Kesler Norman & Wride LLC now owns 6,816 shares of the company’s stock valued at $1,048,000 after acquiring an additional 55 shares in the last quarter. Gen Wealth Partners Inc raised its position in DaVita by 10.0% during the fourth quarter. Gen Wealth Partners Inc now owns 880 shares of the company’s stock worth $100,000 after acquiring an additional 80 shares during the last quarter. NewEdge Advisors LLC lifted its holdings in shares of DaVita by 20.8% in the first quarter. NewEdge Advisors LLC now owns 511 shares of the company’s stock valued at $78,000 after purchasing an additional 88 shares in the last quarter. Finally, Orion Porfolio Solutions LLC lifted its holdings in shares of DaVita by 4.4% in the fourth quarter. Orion Porfolio Solutions LLC now owns 2,360 shares of the company’s stock valued at $268,000 after purchasing an additional 99 shares in the last quarter. Institutional investors and hedge funds own 90.12% of the company’s stock.

DaVita Stock Down 2.0%

Shares of DaVita stock opened at $176.47 on Tuesday. DaVita Inc. has a fifty-two week low of $101.00 and a fifty-two week high of $247.49. The business’s fifty day moving average is $217.03 and its two-hundred day moving average is $180.11. The firm has a market cap of $11.26 billion, a PE ratio of 14.44, a P/E/G ratio of 0.60 and a beta of 0.88.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $4.02 EPS for the quarter, beating analysts’ consensus estimates of $3.88 by $0.14. The business had revenue of $3.55 billion during the quarter, compared to the consensus estimate of $3.50 billion. DaVita had a negative return on equity of 217.63% and a net margin of 6.05%.The business’s revenue for the quarter was up 5.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.95 earnings per share. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. Equities research analysts anticipate that DaVita Inc. will post 14.57 EPS for the current year.

Insider Transactions at DaVita

In other DaVita news, insider Kathleen Alyce Waters sold 15,405 shares of DaVita stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $208.40, for a total value of $3,210,402.00. Following the completion of the sale, the insider owned 109,194 shares in the company, valued at $22,756,029.60. The trade was a 12.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 1.90% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the company. Truist Financial cut their price objective on DaVita from $250.00 to $215.00 and set a “hold” rating for the company in a research report on Friday, August 7th. Weiss Ratings upgraded DaVita from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, August 5th. Oppenheimer set a $220.00 price target on DaVita in a research report on Friday, August 7th. UBS Group upped their price objective on DaVita from $235.00 to $270.00 and gave the company a “buy” rating in a research report on Friday, July 10th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $265.00 price objective on shares of DaVita in a research note on Wednesday, August 5th. Four investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, DaVita presently has a consensus rating of “Hold” and an average target price of $221.75.

DaVita Company Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.